Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Immunotherapy × Breast × Clear all

Status

Not yet recruiting 3 Active not recruiting 3 Recruiting 2 Completed 2 Withdrawn 1 Unknown 1 Terminated 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 14 Gastrointestinal 12 Tumor-Agnostic 2 Head & Neck 2 Gynecologic 2 Dermatologic 2 CNS 2 Plasma cell 1 Other solid neoplasm 1 Lymphoid 1 Genitourinary 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 88 Capecitabine 87 Docetaxel 80 Trastuzumab 79 Paclitaxel 66 Epirubicin 56 pyrotinib 54 Tamoxifen 53 Letrozole 52 Fulvestrant 48 Vinorelbine 43 Carboplatin 42 Doxorubicin 41 Radiotherapy 32 exemestane 31 Anastrozole 31 Neoadjuvant Therapy 29 palbociclib 28 Drug Therapy 26 Fluorouracil 24 Bevacizumab 24 Cisplatin 23 pertuzumab 22 eribulin 22 130-nm albumin-bound paclitaxel 21 Goserelin 20 Gemcitabine 20 Exercise 19 Chemotherapy, Adjuvant 19 liposomal doxorubicin 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05550090 2022-09-27

DreaminLMBC

Zhejiang Cancer Hospital

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡